Health Care • Medical/Dental Instruments
$318.95 ▼ -3.02
(-0.94%)
MKT CAP: $12.68B • VOL: 497.8K
52W L $221 52W H $362
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$268
MEDIAN
$357
MEAN
$364
HIGH
$434
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PEN TAPE
PEN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $385.93 | $366.79 | 2025-02-14 | $290.24 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $401.88 | $376.36 | 2025-02-06 | $299.81 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $363.60 | $350.85 | 2025-01-29 | $306.19 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $325.33 | — | 2025-01-17 | $312.57 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $280.68 | $303.00 | 2025-01-09 | $283.87 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $379.55 | $331.71 | 2024-12-18 | $277.49 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $309.38 | $322.14 | 2024-12-04 | $296.62 | -4.3% | 48% | C |